Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

CDXS Insider Trading

CODEXIS, INC. | Industrial Organic Chemicals

Comprehensive Trading Performance Summary

The investment history of corporate insiders at CODEXIS, INC. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Industrial Organic Chemicals sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2018-12-29 04:17 2018-12-26 WOLF DENNIS P Director SELL $15.83 9,000 $142,425 86,230 -9.5%
2018-12-27 01:15 2018-12-21 KELLEY BERNARD J Director SELL $16.98 10,206 $173,316 205,255 -4.7%
2018-12-22 02:39 2018-12-19 Yang Patrick Y Director SELL $18.52 50,000 $925,950 53,817 -48.2%
2018-12-11 01:36 2018-12-06 NICOLS JOHN J Director, Officer - President and CEO OPT+S $21.78 43,812 $954,041 1,072,679 0.0%
2018-11-15 03:11 2018-11-12 Lalonde James Officer - SVP, R&D SELL $15.40 13,453 $207,112 151,317 -8.2%
2018-10-05 01:36 2018-10-02 SANGSTER GORDON Officer - SVP & Chief Financial Officer OPT+S $16.94 80,000 $1,354,992 134,453 0.0%
2018-10-02 04:52 2018-09-27 NICOLS JOHN J Director, Officer - President and CEO OPT+S $17.57 80,000 $1,405,672 1,072,679 0.0%
2018-09-29 02:46 2018-09-26 WOLF DENNIS P Director SELL $19.17 9,000 $172,522 95,230 -8.6%
2018-09-29 02:42 2018-09-26 BARUCH THOMAS R Director SELL $18.54 25,000 $463,393 128,093 -16.3%
2018-09-28 00:18 2018-09-25 Glaub Kathleen Sereda Director SELL $18.83 14,492 $272,816 63,534 -18.6%
2018-09-26 04:19 2018-09-21 KELLEY BERNARD J Director SELL $18.12 10,207 $184,959 215,461 -4.5%
2018-09-21 01:40 2018-09-19 Glaub Kathleen Sereda Director SELL $17.94 20,094 $360,390 78,026 -20.5%
2018-09-21 01:30 2018-09-18 Yang Patrick Y Director SELL $18.20 50,000 $910,180 103,817 -32.5%
2018-09-07 00:17 2018-09-04 Lalonde James Officer - SVP, R&D SELL $17.24 30,296 $522,197 164,770 -15.5%
2018-09-05 04:03 2018-08-30 KELLEY BERNARD J Director OPT+S $17.15 16,666 $285,780 225,668 0.0%
2018-08-24 00:19 2018-08-21 SANGSTER GORDON Officer - SVP & Chief Financial Officer SELL $15.31 18,736 $286,906 134,453 -12.2%
2018-08-22 01:10 2018-08-17 WOLF DENNIS P Director OPT+S $14.97 36,666 $549,015 104,230 0.0%
2018-08-21 03:51 2018-08-16 Yang Patrick Y Director SELL $14.45 150,340 $2,172,413 0 -100.0%
2018-08-17 00:28 2018-08-14 NICOLS JOHN J Director, Officer - President and CEO OPT+S $15.14 14,259 $215,940 1,072,679 0.0%
2018-07-21 01:37 2018-07-18 Glaub Kathleen Sereda Director SELL $15.34 10,000 $153,400 98,120 -9.2%
2018-07-21 01:36 2018-07-18 Yang Patrick Y Director SELL $15.46 50,000 $772,900 304,157 -14.1%
2018-07-19 01:22 2018-07-16 Lalonde James Officer - SVP, R&D SELL $15.40 15,000 $231,009 195,066 -7.1%
2018-07-18 01:37 2018-07-16 Dorgan Byron L Director SELL $15.49 10,000 $154,880 190,593 -5.0%
2018-06-29 01:59 2018-06-26 WOLF DENNIS P Director SELL $14.47 9,000 $130,210 104,230 -7.9%
2018-06-28 01:01 2018-06-25 BARUCH THOMAS R Director SELL $14.93 25,000 $373,325 153,093 -14.0%
2018-06-23 01:43 2018-06-21 KELLEY BERNARD J Director SELL $16.58 10,206 $169,255 225,668 -4.3%
2018-06-13 04:00 2018-06-12 WOLF DENNIS P Director SELL $14.41 8,947 $128,967 113,230 -7.3%
2018-06-13 02:11 2018-06-08 NICOLS JOHN J Director, Officer - President and CEO OPT+S $15.18 9,007 $136,700 1,072,679 0.0%
2018-05-26 00:38 2018-05-24 SANGSTER GORDON Officer - SVP & Chief Financial Officer SELL $14.11 18,736 $264,307 153,189 -10.9%
2018-05-24 01:04 2018-05-21 Cheng Pam P. Director SELL $14.02 39,215 $549,783 58,719 -40.0%
2018-05-19 00:54 2018-05-17 Aldridge Michael D. Officer - See Remarks OPT+S $13.54 22,000 $297,865 0 0.0%
2018-05-17 03:59 2018-05-15 Aldridge Michael D. Officer - See Remarks OPT+S $12.91 22,000 $283,945 0 0.0%
2018-05-16 02:06 2018-05-14 Lalonde James Officer - SVP, R&D SELL $13.00 20,000 $259,930 210,066 -8.7%
2018-04-05 20:11 2018-04-03 Smith David V Director SELL $10.37 6,000 $62,213 56,679 -9.6%
2018-03-30 18:56 2018-03-28 BARUCH THOMAS R Director SELL $11.05 25,000 $276,318 172,170 -12.7%
2018-03-28 19:27 2018-03-26 WOLF DENNIS P Director OPT+S $11.15 41,666 $464,384 116,254 0.0%
2018-03-24 03:30 2018-03-22 NICOLS JOHN J Director, Officer - President and CEO OPT+S $11.57 22,465 $259,828 1,072,679 0.0%
2018-03-23 01:28 2018-03-21 KELLEY BERNARD J Director SELL $12.22 10,206 $124,683 229,951 -4.2%
2017-12-08 05:22 2015-08-21 Yang Patrick Y Director BUY $3.98 10,000 $39,769 348,234 +3.0%
2017-09-19 03:52 2017-09-14 Vivo Ventures Fund VII, L.P. 10% owner SELL $5.78 1,060,000 $6,121,500 90,330 -92.1%
2016-11-16 03:24 2016-11-15 Yang Patrick Y Director BUY $4.83 10,000 $48,300 320,340 +3.2%
2016-09-13 01:27 2016-09-08 VIVO VENTURES VII, LLC 10% owner SELL $4.25 111,600 $474,624 112,940 -49.7%
2016-08-31 04:37 2016-08-26 WOLF DENNIS P Director SELL $4.22 18,000 $75,974 123,360 -12.7%
2016-08-27 03:02 2016-08-24 KELLEY BERNARD J Director OPT+S $4.26 12,643 $53,807 222,263 0.0%
2016-08-18 02:55 2016-08-15 VIVO VENTURES VII, LLC 10% owner SELL $4.25 86,894 $368,917 115,321 -43.0%
2016-08-06 03:10 2016-08-03 VIVO VENTURES VII, LLC 10% owner SELL $4.22 80,000 $337,368 117,174 -40.6%
2015-11-13 02:46 2015-11-10 Lalonde James Officer - SVP, R&D OPT+S $3.52 9,441 $33,233 168,011 0.0%
2015-09-16 00:00 2015-09-11 Yang Patrick Y Director BUY $3.47 10,000 $34,711 290,246 +3.6%
2015-09-12 00:36 2015-09-10 KELLEY BERNARD J Director OPT+S $3.45 5,200 $17,964 193,146 0.0%
2015-08-25 23:55 2015-08-24 Yang Patrick Y Director BUY $3.84 10,000 $38,353 280,246 +3.7%
SHOW ENTRIES

How to Interpret $CDXS Trades

Not every insider transaction in CODEXIS, INC. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $CDXS shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for CDXS

Insider activity data for CODEXIS, INC. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $CDXS, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.